PTEN and MXI1 allelic loss on chromosome 10q is rare in melanoma in vivo

Archives of Dermatological Research

Volumn 291, Issue 10, 1999, Pages 567-569

  Herbst, Rudolf A ^a   Podewski, Edith K ^a   Mommert, Susanne ^a   Kapp, Alexander ^a   Weiss, Jürgen ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Loss of heterozygosity; Melanoma; MXI1; PTEN MMAC; Tumor suppressor gene

Indexed keywords

DNA MARKER;

ALLELE; ARTICLE; CHROMOSOME 10Q; CONTROLLED STUDY; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0032730079     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050456     Document Type: Article

References (21)

1. Albarosa R, DiDonato S, Finocchiaro G (1995) Redefinition of the coding sequence of the MXI1 gene and identification of a polymorphic repeat in the 3' non-coding region that allows the detection of loss of heterozygosity of chromosome 10q25 in glioblastomas. Hum Genet 95: 709-711
2. Böni R, Vortmeyer AO, Burg G, Hofbauer G, Zhuang Z (1998) The PTEN tumour suppressor gene and malignant melanoma. Melanoma Res 8: 300-302
3. Cappellen D, Gil Diez de Medina S, Chopin D, Thiery JP, Radvanyi F (1997) Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder. Oncogene 14: 3059-3066
4. Dahia PL, FitzGerald, MG, Zhang X, Marsh DJ, Zheng Z, Pietsch T, von Deimling A, Haluska FG, Haber DA, Eng C (1998) A highly conserved processed PTEN pseudogene is located on chromosome band 9p21. Oncogene 16: 2403-2406
5. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV (1995) Mutation of the MXI1 gene in prostate cancer. Nat Genet 9: 249-255
6. Guldberg P, Thor Straten P, Birck A, Ahrenkiel V, Kirkin AF, Zeuthen J (1997) Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57: 3660-3663
7. Healy E, Belgaid C, Takata M, Harrison D, Zhu NW, Burd DA, Rigby HS, Matthews JN, Rees JL (1998) Prognostic significance of allelic losses in primary melanoma. Oncogene 16: 2213-2218
8. Herbst RA, Weiss J, Ehnis A, Cavenee WK, Arden KC (1994) Loss of heterozygosity for 10q22-10qter in malignant melanoma progression. Cancer Res 54: 3111-3114
9. Herbst RA, Gutzmer R, Matiaske F, Mommert S, Casper U, Kapp A, Weiss J (1999) Identification of two distinct deletion targets at 11q23 in cutaneous malignant melanoma. Int J Cancer 80: 205-209
10. Ichimura K, Schmidt EE, Miyakawa A, Goike HM, Collins VP (1998) Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades. Genes Chromosomes Cancer 22: 9-15
11. Indsto JO, Holland EA, Kefford RF, Mann GJ (1998) 10q deletions in metastatic cutaneous melanoma. Cancer Genet Cytogenet 100: 68-71
12. Kim SK, Ro JY, Kemp BL, Lee JS, Kwon TJ, Hong WK, Mao L (1998) Identification of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer. Oncogene 17: 1749-1753
13. Li L, Ernsting BR, Wishart MJ, Lohse DL, Dixon, JE (1997) A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast. J Biol Chem 272: 29403-29406
14. Maier D, Zhang Z, Taylor E, Hamou MF, Gratzl O, Van Meir EG, Scott RJ, Merlo A (1998) Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas. Oncogene 16: 3331-3335
15. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings, BA, Wigler MH, Downes CP, Tonks NK (1998) The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA 95: 13 513-13 518
16. Pesche S, Latil A, Muzeau F, Cussenot O, Fournier G, Longy M, Eng C, Lidereau R (1998) PTEN/MMAC1/TEP1 involvement in primary prostate cancers. Oncogene 16: 2879-2883
17. Rao UNM, Bakker A, Swalsky PA, Finkelstein SD (1999) Max interacting protein 1: loss of heterozygosity is frequent in desmoplastic melanoma. Mod Pathol 12: 344-350.
18. Robertson GP, Furnari FB, Miele ME, Glendening MJ, Welch DR, Fountain JW, Lugo TG, Huang HJ, Cavenee WK (1998) In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma. Proc Natl Acad Sci USA 95: 9418-9423
19. Tsao H, Zhang X, Benoit E, Haluska FG (1998) Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines. Oncogene 16: 3397-3402
20. Wechsler DS, Shelly CA, Petroff CA, Dang CV (1997) MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. Cancer Res 57: 4905-4912
21. Zervos AS, Gyuris J, Brent R (1993) Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72: 223-232